FCP
LLY icon

Fidelis Capital Partners’s Eli Lilly LLY Stock Holding History

Fidelis Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Buy
11,461
+2,867
+33% +$2.93M 0.79% 32
2026
Q1 		$7.9M Buy
8,594
+254
+3% +$258K 0.56% 37
2025
Q4 		$8.96M Buy
8,340
+171
+2% +$164K 0.65% 31
2025
Q3 		$6.23M Buy
8,169
+269
+3% +$200K 0.49% 40
2025
Q2 		$5.9M Sell
7,900
-55
-0.7% -$42.7K 0.54% 36
2025
Q1 		$7.04M Buy
7,955
+776
+11% +$646K 0.75% 30
2024
Q4 		$5.82M Buy
7,179
+236
+3% +$195K 0.58% 34
2024
Q3 		$6.27M Sell
6,943
-849
-11% -$763K 0.75% 27
2024
Q2 		$6.02M Sell
7,792
-297
-4% -$238K 0.86% 25
2024
Q1 		$6.29M Buy
8,089
+2,004
+33% +$1.43M 0.96% 22
2023
Q4 		$3.55M Buy
6,085
+1,385
+29% +$808K 0.78% 25
2023
Q3 		$2.52M Buy
4,700
+367
+8% +$189K 0.86% 20
2023
Q2 		$2.03M Buy
4,333
+224
+5% +$93.9K 0.74% 28
2023
Q1 		$1.76M Buy
4,109
+2,276
+124% +$768K 0.75% 27
2022
Q4 		$641K Buy
+1,833
New +$650K 0.76% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelis Capital Partners's LLY Position: Q2 2026 in Review

Fidelis Capital Partners increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $2.93M and bringing the position to 11,461 shares worth $13.7M. The position accounts for 0.79% of the portfolio, ranked #32.

Fidelis Capital Partners first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fidelis Capital Partners held 11,461 shares of Eli Lilly worth $13.7M as of Q2 2026.
  • Fidelis Capital Partners bought 2,867 Eli Lilly shares in Q2 2026, an estimated $2.93M.
  • Eli Lilly made up 0.79% of Fidelis Capital Partners's portfolio in Q2 2026, its #32 holding.
  • Fidelis Capital Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.